Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
115
datasets available to search
ShareScore release 0.9.0
Dataset results
115 results for “upadacitinib”
A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ank
ClinicalTrials.gov study NCT04541810. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
ClinicalTrials.gov study NCT05843643. IPD Sharing: YES. Countries: 38. Publications: 0.
Real World Study of Oral Upadacitinib Tablets to Assess Adverse Events and Change in Disease Activity in Adolescent and Adult Chinese Participants With Atopic Dermatitis
ClinicalTrials.gov study NCT05959083. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Therapeutic Effect of Upadacitinib in Primary Sjögren's Syndrome
ClinicalTrials.gov study NCT06862284. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING
ClinicalTrials.gov study NCT06712628. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib)
ClinicalTrials.gov study NCT06498167. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate to Severely Active Ulcerative Colitis (UC)
ClinicalTrials.gov study NCT06838845. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT06701331. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Oral Upadacitinib to Assess Change in Disease Activity in Adult Participants With Ulcerative Colitis
ClinicalTrials.gov study NCT05496348. IPD Sharing: UNDECIDED. Countries: 3. Publications: 0.
A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
ClinicalTrials.gov study NCT06454188. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
Upadacitinib Versus IL-17 Inhibitors in Patients With Psoriatic Arthritis
ClinicalTrials.gov study NCT07386717. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Efficacy of Upadacitinib After NECS in Vitiligo
ClinicalTrials.gov study NCT06454461. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowel Disease in Belgium
ClinicalTrials.gov study NCT06581042. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
The Combination of Upadacitinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia
ClinicalTrials.gov study NCT07064889. IPD Sharing: YES. Countries: 1. Publications: 0.
An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in China
ClinicalTrials.gov study NCT06421740. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
ClinicalTrials.gov study NCT06012240. IPD Sharing: YES. Countries: 28. Publications: 0.
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
ClinicalTrials.gov study NCT06332534. IPD Sharing: YES. Countries: 18. Publications: 0.
Upadacitinib for Refractory IBD in Asian Children and Elderly: Age-Stratified Analysis
ClinicalTrials.gov study NCT06922331. IPD Sharing: NO. Countries: 1. Publications: 0.
An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants With Moderate-to-Severe Atopic Dermatitis Who Are Inadequate Responders To or Discontinuing D
ClinicalTrials.gov study NCT05394792. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Assess Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization in Chinese Participants Receiving Upadacitinib for Atopic Dermatitis (AD) Through Chart Review
ClinicalTrials.gov study NCT06503536. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.